InterventionsHuman trial

Safety and tolerability of anselamimab in participants with light chain amyloidosis: Results from a phase 2 study

European Journal of Cancer

The paper

Valent J, Zonder J, Swenson ES et al.

European Journal of Cancer · 10 Sep 2026

doi.org/10.1016/j.ejca.2026.117039 PubMed 42784867

Starting lithium linked to lower death and dementia risks
Frontiers in Neurology · 7 Oct 2026
Human protein variant eased signs of progeria in mice
NPJ Aging · 7 Oct 2026
Boosting sugar breakdown increased bone mass in aged mice
bioRxiv · 7 Oct 2026
Low-carb diet cut fat between muscles in older adults with obesity
Obesity · 7 Oct 2026